End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
105.4 CNY | -4.17% | -7.99% | -16.32% |
Apr. 22 | Anhui Huaheng Biotechnology's Q1 Profit Jumps 7% | MT |
Apr. 22 | Anhui Huaheng Biotechnology's 2023 Profit Jumps 40% | MT |
Sales 2024 * | 3.17B 437M | Sales 2025 * | 4.02B 556M | Capitalization | 16.54B 2.28B |
---|---|---|---|---|---|
Net income 2024 * | 633M 87.41M | Net income 2025 * | 826M 114M | EV / Sales 2024 * | 5.43 x |
Net Debt 2024 * | 664M 91.68M | Net Debt 2025 * | 312M 43.14M | EV / Sales 2025 * | 4.19 x |
P/E ratio 2024 * |
26.2
x | P/E ratio 2025 * |
20.1
x | Employees | - |
Yield 2024 * |
1.16% | Yield 2025 * |
1.38% | Free-Float | 55.99% |
1 day | -4.17% | ||
1 week | -7.99% | ||
Current month | -11.04% | ||
1 month | -1.83% | ||
3 months | -2.97% | ||
6 months | -5.10% | ||
Current year | -16.32% |
Managers | Title | Age | Since |
---|---|---|---|
Geng Hua Guo
CEO | Chief Executive Officer | 60 | 05-04-12 |
Yi Fan
DFI | Director of Finance/CFO | 47 | 15-12-31 |
Xue Li Zhang
CTO | Chief Tech/Sci/R&D Officer | 43 | 13-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Qi Feng Zhang
BRD | Director/Board Member | 51 | 19-07-31 |
Lin Wu
BRD | Director/Board Member | 65 | 22-06-27 |
Heng Ping Guo
FOU | Founder | 62 | 05-04-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +4.20% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 105.4 | -4.17% | 1,308,554 |
24-05-23 | 109.9 | -1.55% | 894,290 |
24-05-22 | 111.7 | -1.05% | 868,354 |
24-05-21 | 112.8 | -0.70% | 1,213,339 |
24-05-20 | 113.6 | -0.75% | 1,252,695 |
End-of-day quote Shanghai S.E., May 23, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.32% | 2.28B | |
-5.11% | 27.61B | |
+5.66% | 11.06B | |
+10.87% | 5.08B | |
+17.91% | 4.44B | |
-12.68% | 3.64B | |
+8.65% | 3.63B | |
-4.63% | 2.84B | |
+23.89% | 2.73B | |
-2.54% | 2.24B |
- Stock Market
- Equities
- 688639 Stock